香港股市 已收市

InspireMD, Inc. (NSPR)

NasdaqCM - NasdaqCM 延遲價格。貨幣為 USD。
加入追蹤清單
2.0000+0.1100 (+5.82%)
收市:04:00PM EDT

InspireMD, Inc.

4 Menorat Hamaor Street
Tel Aviv 6744832
Israel
972 3 6917691
https://www.inspiremd.com

版塊Healthcare
行業Medical Devices
全職員工65

高階主管

名稱頭銜支付行使價出生年份
Mr. Marvin L. SlosmanPresident, CEO & Director843.83k1964
Mr. Craig ShoreCFO, Chief Administrative Officer, Secretary & Treasurer613.49k1961
Mr. Shane Thomas GleasonChief Commercial Officer486.04k1975
Mr. Andrea TommasoliChief Operating Officer359.27k1972
Mr. Amir KohenVice President of Finance & Human Resources
Dr. Patrick A. Verta DVM, M.D., MS StatExecutive Vice President of Clinical & Medical Affairs1958
Mr. Pete LigottiExecutive VP & GM of North America
Dr. Sol J. Barer Ph.D.Special Advisor to the Board13.92k1947
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

公司管治

截至 無 止,InspireMD, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。